Back to Search
AARON CHUNG, PHARMD
PHARMD
Pharmacist
NPI: 1235002445Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PH.60827PH(SC)
Research & Publications (20)
Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease.
PMID 19617223·Cardiovasc Res·2009
8-other
Diabetes modulates capacitative calcium entry and expression of transient receptor potential canonical channels in human saphenous vein.
PMID 19393642·Eur J Pharmacol·2009
8-other
Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9.
PMID 18388324·Circ Res·2008
4-observational
Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction.
PMID 18332634·J Vasc Res·2008
8-other
Mechanical and pharmacological approaches to investigate the pathogenesis of Marfan syndrome in the abdominal aorta.
PMID 18212506·J Vasc Res·2008
7-preclinical
Arterialization of a vein graft promotes cell cycle progression through Akt and p38 mitogen-activated protein kinase pathways: impact of the preparation procedure.
PMID 18060101·Can J Cardiol·2007
7-preclinical
Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
PMID 17641673·Br J Pharmacol·2007
7-preclinical
Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
PMID 17641224·Circ Res·2007
4-observational
Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
PMID 17339838·Br J Pharmacol·2007
7-preclinical
Pharmacologic relaxation of vein grafts is beneficial compared with pressure distention caused by upregulation of endothelial nitric oxide synthase and nitric oxide production.
PMID 17000306·J Thorac Cardiovasc Surg·2006
4-observational
Reduced expression of vascular endothelial growth factor paralleled with the increased angiostatin expression resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in human type 2 diabetic arterial vasculature.
PMID 16778129·Circ Res·2006
8-other
Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
PMID 16242564·J Vasc Surg·2005
4-observational
Fibroblasts regulate monocyte response to ECM-derived matrix: the effects on monocyte adhesion and the production of inflammatory, matrix remodeling, and growth factor proteins.
PMID 19437738·J Biomed Mater Res A·2009
8-other
A robust, electrochemically driven microwell drug delivery system for controlled vasopressin release.
PMID 19353273·Biomed Microdevices·2009
7-preclinical
Microbial production of 3-hydroxydodecanoic acid by pha operon and fadBA knockout mutant of Pseudomonas putida KT2442 harboring tesB gene.
PMID 19271216·Appl Microbiol Biotechnol·2009
8-other
Antibody array platform to monitor protein tyrosine phosphorylation in mammalian cells.
PMID 19241018·Methods Mol Biol·2009
6-review
Engineering insect flight metabolics using immature stage implanted microfluidics.
PMID 19224016·Lab Chip·2009
7-preclinical
Monocyte inflammatory and matrix remodeling response modulated by grafted ECM-derived ligand concentration.
PMID 19051303·J Biomed Mater Res A·2009
8-other
Acute heart failure syndromes: potential strategies to improve post-discharge outcomes.
PMID 18647590·Curr Treat Options Cardiovasc Med·2008
8-other
Use of second-generation antiepileptic drugs in the pediatric population.
PMID 18590343·Paediatr Drugs·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 14 RICHLAND MEDICAL PARK DR STE 210
COLUMBIA, SC 29203 - Phone
- (803) 434-6482
Quick Facts
- NPI
- 1235002445
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile